Office consultant

Clarity Pharma, a UK headquartered distribution partner to mid-market pharmaceutical companies around the world, has announced that a March 2021 audit saw Unit 1 of its warehousing infrastructure achieve Medical Healthcare Regulatory Agency (MHRA) licence approval. The accreditation is in compliance with the new Medical Device Regulations, which came into place in May 2020, and complements the company’s existing licence for its Unit 3 facility.

 

Clarity Pharma holds an MHRA wholesale dealer licence (H) for the storage and distribution of POM and GSL healthcare products. This state-of-the-art third party logistics warehouse opened its doors in March 2019 providing a purpose-built pharmaceutical distribution facility including dedicated chilled and controlled drugs storage areas, with benchmark safety and security measures in place.

 

The warehouse is designed to support the company’s market position offering multi-channel pharmaceutical and

Read more »